210 related articles for article (PubMed ID: 10739667)
1. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction.
Sumi Y; Muramatsu H; Hata K; Ueda M; Muramatsu T
Exp Cell Res; 2000 Apr; 256(1):203-12. PubMed ID: 10739667
[TBL] [Abstract][Full Text] [Related]
2. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor.
Angelov N; Moutsopoulos N; Jeong MJ; Nares S; Ashcroft G; Wahl SM
Thromb Haemost; 2004 Aug; 92(2):288-97. PubMed ID: 15269824
[TBL] [Abstract][Full Text] [Related]
3. Temporal stimulation of corneal fibroblast wound healing activity by differentiating epithelium in vitro.
Daniels JT; Khaw PT
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3754-62. PubMed ID: 11053273
[TBL] [Abstract][Full Text] [Related]
4. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices.
Mukhopadhyay A; Tan EK; Khoo YT; Chan SY; Lim IJ; Phan TT
Br J Dermatol; 2005 Apr; 152(4):639-45. PubMed ID: 15840092
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.
Zhang Z; Garron TM; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Burns; 2009 Jun; 35(4):527-37. PubMed ID: 19167828
[TBL] [Abstract][Full Text] [Related]
6. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
7. SB-431542 inhibits TGF-beta-induced contraction of collagen gel by normal and keloid fibroblasts.
Hasegawa T; Nakao A; Sumiyoshi K; Tsuchihashi H; Ogawa H
J Dermatol Sci; 2005 Jul; 39(1):33-8. PubMed ID: 15978417
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic differences between oral and skin fibroblasts in wound contraction and growth factor expression.
Shannon DB; McKeown ST; Lundy FT; Irwin CR
Wound Repair Regen; 2006; 14(2):172-8. PubMed ID: 16630106
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.
Ashcroft GS; Lei K; Jin W; Longenecker G; Kulkarni AB; Greenwell-Wild T; Hale-Donze H; McGrady G; Song XY; Wahl SM
Nat Med; 2000 Oct; 6(10):1147-53. PubMed ID: 11017147
[TBL] [Abstract][Full Text] [Related]
10. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture.
Fahey JV; Wira CR
J Infect Dis; 2002 Jun; 185(11):1606-13. PubMed ID: 12023766
[TBL] [Abstract][Full Text] [Related]
11. SPARC from corneal epithelial cells modulates collagen contraction by keratocytes.
Mishima H; Hibino T; Hara H; Murakami J; Otori T
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2547-53. PubMed ID: 9856764
[TBL] [Abstract][Full Text] [Related]
12. Mitosis increases levels of secretory leukocyte protease inhibitor in keratinocytes.
Lai JY; Borson ND; Strausbauch MA; Pittelkow MR
Biochem Biophys Res Commun; 2004 Apr; 316(2):407-10. PubMed ID: 15020232
[TBL] [Abstract][Full Text] [Related]
13. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
Westin U; Lundberg E; Ohlsson K
Mediators Inflamm; 1998; 7(3):217-20. PubMed ID: 9705610
[TBL] [Abstract][Full Text] [Related]
14. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
15. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
Westin U; Polling A; Ljungkrantz I; Ohlsson K
Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the secretory phenotype of human airway epithelium by retinoic acid, triiodothyronine, and extracellular matrix.
Yoon JH; Gray T; Guzman K; Koo JS; Nettesheim P
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):724-31. PubMed ID: 9191474
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
19. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1, TGF-beta3, and PGE(2) regulate contraction of human patellar tendon fibroblasts.
Campbell BH; Agarwal C; Wang JH
Biomech Model Mechanobiol; 2004 Jun; 2(4):239-45. PubMed ID: 15103516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
